Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Supernus Pharmaceuticals (SUPN)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2023 Q2 | 7,409 | <0.01 | Reduce 11.86% | <0.01 | $30.06 | $222,715 | SEC |
| 2023 Q1 | 8,406 | 0.01 | Add 9.01% | <0.01 | $36.23 | $304,549 | SEC |
| 2022 Q4 | 7,711 | 0.01 | Reduce 13.22% | <0.01 | $35.67 | $275,051 | SEC |
| 2022 Q3 | 8,886 | 0.01 | Buy | 0.01 | $33.87 | $301,000 | SEC |
| 2022 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2021 Q4 | 4,000 | <0.01 | Reduce 90.47% | <0.01 | $29.25 | $117,000 | SEC |
| 2021 Q3 | 41,962 | 0.01 | Reduce 26.71% | <0.01 | $26.67 | $1,119,000 | SEC |
| 2021 Q2 | 57,251 | 0.02 | Buy | 0.02 | $30.79 | $1,763,000 | SEC |
| 2021 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2020 Q4 | 1,711 | <0.01 | Reduce 97.41% | 0.03 | $25.13 | $43,000 | SEC |
| 2020 Q3 | 66,177 | 0.03 | Buy | 0.03 | $20.84 | $1,379,000 | SEC |